DE-ESCALATE
INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL
| Grant period | 2023-06-01 - 2028-05-31 |
| Funding body | European Union |
| Call number | HORIZON-MISS-2022-CANCER-01 |
| Grant number | 101104574 |
| Identifier | G:(EU-Grant)101104574 |